DCGI issues notices to Tata 1mg, Amazon and 18 Other epharmacies for rule violations

February 10, 2023

Share via:

The DCGI has issued show-cause notices to 20 epharmacies, including Tata 1mg, Amazon, and Flipkart, for selling and distributing drugs in violation of the Drugs and Cosmetics Act, 1940.

The companies have been asked to explain why they should not face consequences for breaking the rules. The Drugs and Cosmetics Act of 1940 governs drug importation, manufacturing, and distribution in India. The DCGI stated in the notice that the sale, stock, exhibit, or offer for sale or distribution of drugs through online, internet, or other electronic platforms without a licence may have an impact on drug quality and pose a risk to public health due to potential drug misuse through self-medication and indiscriminate use of the drugs.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Previous News

PB Fintech’s Q3 loss drops 70% year on year to INR 87.6 Cr; Paisabazaar adjusted EBITDA positive

Next News

Social media app Slick exposed childrens’ user data

Editorial Team

StartupNews.fyi is a leading global startup and technology media platform known for its end-to-end coverage of the startup ecosystem across India and key international markets. Launched with the vision of becoming a single gateway for founders, investors, and ecosystem enablers, StartupNews.fyi has grown steadily over the years by publishing tens of thousands of verified news stories, insights, and ecosystem updates, reaching millions of startup enthusiasts every month through its digital platforms and communities.

DCGI issues notices to Tata 1mg, Amazon and 18 Other epharmacies for rule violations

February 10, 2023

, By Editorial Team

E Commerce

The DCGI has issued show-cause notices to 20 epharmacies, including Tata 1mg, Amazon, and Flipkart, for selling and distributing drugs in violation of the Drugs and Cosmetics Act, 1940.